Q4 2022 Holdings
Filed 2023-02-10 | 14 holdings | $104.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $41.3M | 5,903,405 | 39.4% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $14.1M | 722,080 | 13.5% |
| Invivyd Inc(IVVD) | COM | 00534A102 | $13.9M | 9,248,250 | 13.2% |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | $7.1M | 1,910,600 | 6.7% |
| Arrowhead Pharmaceuticals in(ARWR) | COM | 04280A100 | $5.8M | 143,900 | 5.6% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $4.8M | 126,300 | 4.5% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $4.5M | 482,890 | 4.2% |
| Bridgebio Pharma Inc(BBIO) | COM | 10806X102 | $3.2M | 419,000 | 3.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $2.9M | 109,900 | 2.7% |
| Curis Inc(CRISEUR) | COM NEW | 231269200 | $2.5M | 4,482,142 | 2.3% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $2.2M | 145,900 | 2.1% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $1.4M | 439,300 | 1.4% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $1.2M | 104,400 | 1.2% |
| Neximmune Inc | COM | 65344D109 | $32.4K | 133,442 | 0.0% |